Dissection of a novel molecular determinant mediating Golgi to trans -Golgi network transition by Schaub, B. et al.
Research Article
Dissection of a novel molecular determinant mediating Golgi to
trans-Golgi network transition
B. E. Schaub, E. G. Berger and J. Rohrer+ ,*
University of Zurich, Institute of Physiology, Winterthurerstr. 190, 8057 Zurich (Switzerland)
Received 30 July 2008; received after revision 17 September 2008; accepted 29 September 2008
Online First 27 October 2008
Abstract. Two major functions of the Golgi apparatus
(GA) are formation of complex glycans and sorting of
proteins destined for various subcellular compart-
ments or secretion. To fulfill these tasks proper
localization of the accessory proteins within the
different sub-compartments of the GA is crucial.
Here we investigate structural determinants media-
ting transition of the two glycosyltransferases b-1,4-
galactosyltransferase 1 (gal-T1) and the a-1,3-fucosyl-
transferase 6 (fuc-T6) from the trans-Golgi cisterna to
the trans-Golgi network (TGN). Upon treatment with
the ionophoremonensin both glycosyltransferases are
found in TGN-derived swollen vesicles, as determined
by confocal fluorescence microscopy and density
gradient fractionation. Both enzymes carry a signal
consisting of the amino acids E5P6 in gal-T1 and D2P3
in fuc-T6 necessary for the transition of these glyco-
syltransferases from the trans-Golgi cisterna to the
TGN, but not for their steady state localization in the
trans-Golgi cisterna.
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Introduction
The Golgi apparatus (GA) plays a major role in
protein sorting and maturation. Secretory and mem-
brane proteins destined for post-Golgi compartments
pass through the GA where they are subjected to
various structural changes such as glycosylation,
acylation, sulfation and processing. The GA is the
site where complex N-glycans are elongated and
terminated. The enzymes involved in formation of
complex glycans are the glycosyltransferases, which
are all type II membrane proteins [1]. To fulfill their
task they appear to be sequentially arranged along the
cis- to trans-Golgi cisternal axis. Current evidence
suggests co-localization of b-1,4-galactosyltransferase
1 (gal-T1; EC 2.4.1.38) with a-2,6-sialyltransferase 1
(sia-T1; EC 2.4.99.1) in trans-Golgi cisternae, while
enzymes acting beforehand such as N-acetylglucosa-
minyltransferase I and mannosidase II are concen-
trated in medial cisternae [2]. How this sequential
order of glycosyltransferases is established is not
understood and several models have been proposed.
In one model the length of the transmembrane
domain determines the cisternal localization [3] yet
it can not sufficiently explain the different dynamics of
individual glycosyltransferases when the cells are
treatedwithGolgi-disturbing agents such asmonensin
[4]. Evidence for another model involving Golgi
matrix proteins for correct cisternal localization of
glycosyltransferases has been proposed [5 – 7] that
suggests that the cytoplasmic tail of glycosyltransfer-
ases can interact with Golgi matrix proteins and help
mediating their correct localization.
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In the search for trafficking determinants for glyco-
syltransferases, in this study we investigated twoGolgi
glycosyltransferases, gal-T1, and the a-1,3-fucosyl-
transferase 6 (fuc-T6, EC not specified), both of which
are sensitive to monensin treatment [4, 8, 9]. Trans-
lation initiation of gal-T1 can occur alternatively at
either one of the two in-framemethionines resulting in
a long form (24 amino acids) and a short form (12
amino acids) of the cytosolic tail. In addition, gal-T1
has been shown to be phosphorylated on serine
residues within the cytosolic tail. Both features have
been suggested to affect its trafficking behavior and/or
monensin sensitivity [10, 11]. Treatment with this
ionophore is used as a short-term read-out system to
studyGolgi to TGN translocation [4, 12]. Monensin, a
carboxylic ionophore, leads to the efflux of protons
from acidic post-Golgi organelles in exchange for
sodium ions, followed by osmotic swelling of the
endomembranes [13, 14] and the formation of TGN
derived swollen vesicles [4, 12, 15], while the Golgi
cisternae remain intact. These swollen vesicles contain
gal-T1, fuc-T6 as well as the TGNmarker TGN46 and
CI-MPR [12], but are devoid of sia-T1 another trans-
Golgi glycosyltransferase, which co-localizes with gal-
T1 in untreated cells [4, 16, 17]. Short-term incubation
with 2 mMmonensin for 30 min leads to the formation
of TGN-derived swollen vesicles, whereas prolonged
treatment with 10 mMmonensin leads to the accumu-
lation of TGN46 and GPP130 in smaller peripheral
structures [18].
Here we show qualitatively by confocal fluorescence
microscopy as well as quantitatively by subcellular
fractionation that the re-distribution of gal-T1 from
the trans-cisterna to the TGN is mediated by a short
amino acid signal consisting of a glutamic acid and a
proline in its cytoplasmic tail. We extend this obser-
vation to fuc-T6, which carries a similar determinant
on its cytoplasmic tail consisting of aspartic acid and
proline. This [DE]P signal appears to be required for
the anterograde transport of two glycosyltransferases
from the trans-cisternae to the TGN.
Materials and methods
Materials. Chemicals were from AppliChem (Chesh-
ire, CT) or Sigma-Aldrich (St. Louis, MO). Monensin
was from Axxora Life Sciences Inc. (San Diego, CA).
OptiPrepwas obtained fromSigma-Aldrich. Enzymes
used in molecular cloning were either from New
England Biolabs (Ipswich, MA), Promega (Madison,
WI), Roche Diagnostics (Basel, Switzerland), or
Sigma-Aldrich. Nitrocellulose was from Whatman
PLC (Florham Park, NJ); the ECLWestern blotting
reagents were from PerkinElmer Life Sciences (Wal-
tham,MA). Polyethylenimine (PEI; linear,Mr 25 000)
used for transfection was from Polysciences Inc.
(Warrington, PA), Dulbeccos modified Eagle medi-
um (DMEM) and bovine fetal calf serum (FCS) were
from Invitrogen (Carlsbad, CA). Disposable plastic
ware and cell culture dishes were from TPP (Trasa-
dingen, Switzerland), VWR (Wien, Austria), Greiner
Bio One (Monroe, NC) or Bioswisstec (Schaffhausen,
Switzerland). DNA synthesis and oligonucleotide
sequencing was performed by Microsynth GmBH
(Galbach, Switzerland).
Antibodies. The monoclonal antibody to gal-T1 was
gal-T1#2/36/118 [19], the monoclonal antibody to
giantin (G1/133) was from Axxora Life Sciences Inc.
and the monoclonal antibody to GFPwas fromRoche
Diagnostics. The monoclonal goat anti-mouse anti-
body conjugated with Alexa 568 was from Molecular
Probes (Eugene, OR) or conjugated with horseradish
peroxidase (HRP) from GE Healthcare (Chalfont St.
Giles, UK).
OptiPrep density gradient. The OptiPrep density
gradient was performed according to the manufactur-
ers protocol (Axis Shield, protocol S36) andmodified
as described in Schaub et al. [4]. In brief, HepG2 cells
were seeded on 10-cm plates and grown to 70 – 80%
confluency in DMEM containing 10% FCS. The cells
were then either incubated with 8 ml fresh DMEM +
10% FCS or 8 ml fresh DMEM + 10% FCS + 2 mM
monensin for 30 min at 378C. Thereafter the cells were
transferred onto ice and washed twice with ice-cold
PBS and once with homogenization buffer (0.25 M
sucrose, 1 mM EDTA, 10 mM HEPES-NaOH,
pH 7.4). The cells were then harvested in 2 ml
homogenization buffer using a rubber policeman. To
homogenize the cells, they were passed 15 times
through a ball bearing homogenizer with a clearance
of 16 mmand centrifuged at 800 g to remove unbroken
cells and nuclei. Subsequently, 0.8 ml homogenate was
loaded onto an OptiPrep step gradient containing
2.5 – 30% iodixanol (final volume of 9.2 ml: 0.8 ml
2.5%; 1.3 ml each of 5%, 7.5% and 10%; 0.8 ml
12.5%; 1.3 ml 15%; and 0.8 ml each of 17.5%, 20%
and 30%). The gradient was centrifuged for 2.5 h at
200 000 gav in the Sorvall TH-641 swing-out rotor.
Finally, ten fractions of 1 ml were collected from the
bottom by perforating the tube with aG21 needle, and
proteins were precipitated using trichloroacetic acid
(TCA) as described below, then analyzed by Western
blotting using an anti-GFP antibody.
SDS-PAGE, immunoblotting and quantification.
Using the Laemmli [20] system the proteins were
separated on 10% SDS-polyacrylamide minigels
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(Bio-Rad, Hercules, CA) and then transferred to
nitrocellulosemembranes using themethod described
by Towbin et al. [21]. Immunoblotting was performed
as described previously [22]. In short, membranes
were washed in phosphate-buffered saline (PBS) and
then blocked for 30 min using 3% milk in PBS
containing 0.01% thimerosal. Anti-GFP antibody
was applied overnight at 48C in PBS containing 3%
milk. After washing in PBS the secondary antibody
conjugated with HRP was applied for 1 h in PBS
containing 3% milk and, after final washing, the
chemiluminescence was recorded using the quantita-
tive densitometer from Raytest (Straubenhardt, Ger-
many). Subsequently, the recorded data were ana-
lyzed using the Aida Software (Straubenhardt, Ger-
many).
Confocal immunofluorescence imaging. For immuno-
fluorescence imaging, cells were grown on coverslips
to a density of ~50% and either incubated with fresh
growth media with or without 2 mM monensin for
30 min. The cells were then washed in PBS and fixed
using 3% paraformaldehyde (PFA) in PBS. The cells
were washed with PBS-glycine (20 mM glycine in
PBS) and solubilized using PBS-glycine-saponin (PBS
containing 0.1% saponin and 20 mM glycine). Sub-
sequently, the cells were incubated in the first anti-
body diluted in PBS-saponin (PBS containing 0.1%
saponin), washed four times in PBS-saponin, incu-
bated with the secondary antibody conjugated with
the fluorophore in PBS-saponin, washed again four
times in PBS-saponin and finally mounted on a glass
slide using Prolong Gold antifade (Invitrogen, Carls-
bad, CA). The pictures were recorded using a Leica
SP5 confocal laser scanning microscope and analyzed
using the Imaris software from Bitplane (Zurich,
Switzerland).
TCA precipitation. For TCA precipitation, the col-
lected 1-ml gradient fractions were supplemented
with 190 ml 0.15% deoxycholate, 20 mg bovine serum
albumin (BSA) and mixed thoroughly. Then 200 ml
100% TCAwas added and the mixture was incubated
for 1 h to overnight on a rotating shaker at 48C. The
proteins were then collected by centrifugation (Max
speed for 30 min at 48C) and washed twice using cold
acetone (stored at – 208C). Finally, the pellet was re-
suspended in protein gel-loading buffer.
Generation of mutant gal-T1 and fuc-T6 constructs.
To generate the novel gal-T1-GFP mutants, vector
containing gal-T1-GFP [4] was digested using XbaI
and SfaNI. Complementary oligos, encoding for the
mutant cytoplasmic tail with overhangs compatible
with the XbaI/SfaNI-digested vector containing gal-
T1-GFP, were annealed by heating them to 948C and
then slowly cooled in ligation buffer. The annealed
oligos were then directly ligated into the XbaI/SfaNI
open vector containing gal-T1-GFP. The fuc-T6-RFP
construct used as template was a gift from L. Borsig.
First the pFX vector was prepared by removing the
nativeBglII site frompcDNA3.1 (Invitrogen) and gal-
T1-GFP [4] was sub-cloned into this vector. The
cytoplasmic tail, transmembrane domain and stem
region of fuc-T6 were amplified by PCR using
oligonucleotides containing either the XbaI site and
wild-type or mutant tail sequence for the sense oligo
or the BglII restriction site in the antisense oligo.
Finally, the PCR product was sub-cloned into XbaI/
BglII open pFX containing GFP. Further details are
given in the supplementary material.
Tissue culture and transfection. HepG2 cells were
grown in DMEM + 10% FCS at 378C in a 5% CO2
atmosphere. Transfection was performed according to
the protocol from Polyplus-Transfection (Illkirch,
France). In brief, HepG2 cells were grown in six-well
plates to a confluency of ~25%. DNA (4.4 mg) and
PEI (15 mg) were mixed and then added to the cells in
1 ml of culture media. At 24 h after transfection the
cells were washed with fresh culture media. At 48 h
post transfection the cells were trypsinized and seeded
on 10-cm plates at dilutions 1:10, 1:100 and 1:1000.
Finally, at 3 – 4 weeks post transfection clonal colo-
nies were picked and expanded for analysis.
Results
E5P6 motif in the cytoplasmic tail of gal-T1-GFP is
required for redistribution of gal-T1-GFP chimera
into TGN-derived swollen vesicles.Gal-T1 and sia-T1
share a similar domain structure and localization to
the trans-cisternae of the GA [16], and they catalyze
subsequent steps in glycosylation. Both enzymes are
readily redistributed to the endoplasmic reticulum
(ER) upon brefeldin A treatment [4] showing that
they are not localized to the TGN but to the Golgi
cisternae. However, using the carboxylic ionophore
monensin as short-term read out system, we could
show that sia-T1 remains in the perinuclear region
together with other Golgi markers such as giantin,
while gal-T1 separated from theGAand redistributed
to TGN-derived swollen vesicles [4]. This displace-
ment is referred to here as “monensin sensitivity”. We
also demonstrated that replacement of the catalytic
domain of gal-T1 with green fluorescent protein
(GFP) neither altered its subcellular localization nor
influenced its response to monensin. Using GFP
chimerae we showed that the first 13 amino acids of
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the cytoplasmic tail of gal-T1 (unique to the long form
of gal-T1) are necessary for redistribution of gal-T1 to
TGN-derived swollen vesicles. In addition, we dem-
onstrated that the two potential phosphorylation sites
S9 and S11 are not necessary formonensin sensitivity of
gal-T1. We therefore generated three novel alanine
mutants scanning for the crucial amino acids involved
in monensin-induced redistribution of gal-T1 (Fig. 1).
All three mutant chimerae co-localized with endog-
enous giantin in the same structures of the perinuclear
region in untreated cells as shown by confocal
fluorescence microscopy (Fig. 2A – C), indicating a
correct localization of the mutant fusion protein. The
overlap between gal-T1 and its derivatives with
giantin is significant, albeit not complete as giantin
staining appears more on the periphery of the GA
enclosing gal-T1 staining [23]. Treatment with brefel-
din A redistributed all the GFP chimerae to the ER,
further substantiating their Golgi localization and
excluding a steady-state accumulation in the TGN
(data not shown). The two mutants gal-T1-R2L3
R4>AAA-GFP and gal-T1-L7L8>AA-GFP behaved
as wild-type gal-T1-GFP in monensin-treated cells
andmoved to swollen vesicles (Fig. 2D, F). In contrast,
gal-T1-E5P6>AA-GFP showed little reaction to mon-
ensin treatment and remained in the perinuclear
region co-localizedwith endogenous giantin (Fig. 2E).
To test the contribution of E5 and P6 to monensin
sensitivity of gal-T1, we created additional mutants
replacing the two amino acids individually by alanine
(Fig. 1). Both single alanine mutants (gal-T1-E5>A-
GFP and gal-T1-P6>A-GFP) co-localized to the GA
together with giantin in untreated cells (Fig. 3A, B)
and were redistributed to the ER upon treatment with
brefeldin A (data not shown). Upon treatment with
monensin their localization remained unchanged in
the GA, where they were co-localized with giantin
(Fig. 3C, D), showing that E5 and P6 are crucial for
monensin-induced redistribution of gal-T1 into TGN-
derived swollen vesicles.
To confirm these results by a quantitative approach,
cell homogenates were fractionated on an OptiPrep
Figure 1. Overview of GFP-con-
jugated glycosyltransferases b-1,
4-galactosyltransferase 1 (gal-T1-
GFP), a-1,3-fucosyltransferase 6
(fuc-T6-GFP) and their mutants.
Figure 2.Fluorescence ofHepG2
cells stably transfected with gal-
T1-R2L3R4>AAA-GFP, gal-T1-
E5P6>AA-GFP and gal-T1-L7
L6>AA-GFP (all in green) and
immunolabeled with a monoclo-
nal antibody against giantin
(red). All three mutants co-local-
ize with giantin (A, B and C,
respectively) in untreated cells.
Upon treatment with 2 mMmon-
ensin for 30 min both gal-T1-R2
L3R4>AAA-GFP (D) and gal-
T1-L7L6>AA-GFP (F) separate
from giantin and are found in
swollen vesicles (arrows). In con-
trast the gal-T1-E5P6>AA-GFP
mutant is not redistributed to
swollen vesicles and remains co-
localized with giantin (E). Bar
10 mm
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density gradient to separate swollen vesicles from the
GA. In this gradient densemembranes such as the ER
accumulate in the lower fractions and the GA located
to fractions 4 – 6. The swollen vesicles floated towards
the lightest fractions 7 – 10. Both gal-T1-R2L3
R4>AAA-GFP and gal-T1-L7L8>AA-GFP showed
a clear shift towards the lighter fractions 7 – 10,
representing 40.7% and 16.9% of total immunoreac-
tive protein loaded on the gradient, respectively, when
comparing monensin-treated cells with untreated
cells, showing the redistribution of the two chimerae
to the swollen vesicles (Table 1). In contrast, only a
slight shift of the gal-T1-E5P6>AA-GFP mutant was
found, representing 13.7% in the lighter fractions in
monensin-treated cells, which was only 4.3% higher
than the value in untreated cells. These data are in
accordance with the results observed by fluorescence
microscopy (Table 1).
In gradients of untreated cells, gal-T1-E5>A-GFP and
gal-T1-P6>A-GFP showed a clear peak in fractions
5 – 6 and 5 – 7, respectively (Fig. 3E, F). Neither
mutant redistributed towards the lighter fractions
upon monensin treatment since gal-T1-E5>A-GFP
peaked in fractions 4 – 6 and gal-T1-P6>A-GFP in
fractions 5 – 6 (Fig. 3G, H). Quantification of the
single mutants showed that gal-T1-E5>A-GFP and
gal-T1-P6>A-GFP was found in fractions 7 – 10 to the
same extent in monensin-treated cells as in untreated
cells with a difference of only 2.3% and 1.5%,
respectively, which was also in accordance with the
results obtained by fluorescence microscopy.
D2P3 motif in the cytoplasmic tail of fuc-T6 is crucial
for the monensin sensitivity of fuc-T6. To test
whether the motif found in gal-T1 is unique or a
more general signal we investigated fuc-T6, a
glycosyltransferase previously shown to be monen-
sin sensitive [8] . Fuc-T6 co-localizes with giantin and
gal-T1 in the GA (Figs 4A, 5A). As expected, upon
treatment with monensin, fuc-T6 was redistributed
to TGN-derived swollen vesicles, where it was co-
localized with gal-T1 but not giantin (Figs 5C, 4C).
Since the sequence D2P3 in the cytoplasmic tail of
Figure 3. (A – D) Fluorescence of HepG2 cells stably transfected
with gal-T1-E5>A-GFP and gal-T1-P6>A-GFP (green) and im-
munolabeled with a monoclonal antibody against giantin (red).
Both mutants co-localize with giantin (A and B, respectively) in
untreated cells. Upon treatment with 2 mM monensin for 30 min
neither of the mutants is displaced and they remain co-localized
with giantin. Bar 10 mm. (E – H) OptiPrep density gradient of
HepG2 cells stably transfected with gal-T1-E5>A-GFP or gal-T1-
P6>A-GFP. The density of membranes found in fraction 1 is
highest and decreases towards fraction 10. Both gal-T1-E5>A-
GFP and gal-T1-P6>A-GFP culminate in fractions 5 and 6 in
untreated cells (E and F). No shift towards lighter fractions can be
observed upon treatment with 2 mM monensin for 30 min (G and
H), indicating monensin insensitivity of the two mutants.
Figure 4. (A – D) Fluorescence of HepG2 cells stably transfected
with fuc-T6-GFP and fuc-T6-D2P3>AA-GFP (green) and immu-
nolabeled with a monoclonal antibody against giantin (red). Both
mutants co-localize with giantin (A and B, respectively) in un-
treated cells. Upon treatment with 2 mMmonensin for 30 min fuc-
T6-GFP separates from giantin and is found in swollen vesicles (C),
whereas the mutant fuc-T6-D2P3>AA-GFP remains co-localized
with giantin in the Golgi apparatus (GA) (D). Bar 10 mm
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fuc-T6 is similar to the E5P6 motif of gal-T1 we
generated the fuc-T6-D2P3>AA-GFPmutant to test
if these two amino acids exert the same function in
fuc-T6 as E5P6 in gal-T1 (Fig. 1). In untreated cells
the fuc-T6-D2P3>AA-GFP co-localized together
with giantin and endogenous gal-T1 in the GA
(Figs 4B, 5B). Like the gal-T1-E5P6>AA-GFP mu-
tant, the fuc-T6-D2P3>AA-GFP mutant was unaf-
fected by treatment with monensin and remained in
the GA together with giantin (Fig. 4D), while
endogenous gal-T1 was separated from the mutant
and segregated into swollen vesicles (Fig. 5D).
To confirm these findings, segregation of fuc-T6 was
also analyzed by cell fractionation using OptiPrep
density gradient as described above. Both fuc-T6-GFP
and fuc-T6-D2P3>AA-GFP showed a strong peak in
fractions 4 – 5 in gradients obtained from untreated
cells (Fig. 5E, F). The fuc-T6-GFP chimerae showed a
substantial shift towards the lighter fractions 7 – 10 in
cells treated with monensin (28.5% more than for
untreated cells) (Fig. 5G). Unlike the wild-type fuc-
T6-GFP chimerae, the mutant fuc-T6-D2P3>AA-
GFP chimerae did not shift towards the lighter
fractions and remained in the peak fractions 5 – 6.
There was no difference in the amount of fuc-T6-D2
P3>AA-GFPwhen comparingmonensin-treated cells
to untreated cells (Fig. 5H).
These quantitative results from the OptiPrep density
gradients confirmed that the motif D2P3 is analogous
to E5P6 of gal-T1 in determining monensin-induced
redistribution of fuc-T6 into TGN-derived swollen
vesicles. Taken together these results suggest that the
determinant [ED]P exerts a function mediating Golgi
to TGN transition.
Replacement of E5 with aspartic acid in gal-T1-GFP
and of D2 with glutamic acid in fuc-T6-GFP strongly
reduces monensin sensitivity of the two mutants. We
also replaced E5 with aspartic acid in gal-T1-GFP and
D2 with glutamic acid in fuc-T6-GFP (Fig. 1) to test
whether the two signals from gal-T1 and fuc-T6 can
substitute for each other. In control cells, both gal-T1-
E5>D-GFP and fuc-T6-D2>E-GFP co-localized with
giantin in the GA (Fig. 6A, B). Upon treatment with
monensin only a small amount of gal-T1-E5>D-GFP
was found in swollen vesicles, while most of the
mutant remained co-localized with giantin in the GA
(Fig. 6C). Like gal-T1-E5>D-GFP, only a small frac-
tion of the fuc-T6-D2>E-GFP mutant was found in
swollen vesicles after monensin treatment, while the
majority remained in the GA where it co-localized
with giantin (Fig. 6D).
These findings were further validated using the
OptiPrep density gradient. In gradients of untreated
cells both mutant chimerae were strongly enriched in
fractions 4 – 5 (Fig. 6E, F). Upon treatment with
monensin, only 11.6% more of the gal-T1-E5>D-
GFP were found in fractions 7 – 10 when compared to
untreated cells showing a clear reduction of redistrib-
ution of the mutant into swollen vesicles (Fig. 6G).
Accordingly, the fuc-T6-D2>E-GFP only showed
12.3% more floating towards fractions 7 – 10 upon
treatment with monensin compared to untreated cells
(Fig. 6H). Thus, both gal-T1-E5>D-GFP and fuc-T6-
Table 1. Quantification of monensin sensitivity.
% of total immunoreactive protein loaded on gradient found in fractions 7 – 10
Control Monensin treated
gal-T1-GFP 20.2  8.5 58.6  11.4*
sia-T1-GFP 21.3  6.2 22.3  7.5*
gal-T1-R2L3R4>AAA-GFP 8.6  7.3 49.3  8.8 Fig. 2A, D
gal-T1-E5P6>AA-GFP 9.4  5.4 13.7  4.8 Fig. 2B, E
gal-T1-L7L8>AA-GFP 11.2  6.6 28.1  7.2 Fig. 2C, F
gal-T1-E5>A-GFP 17.2  4.7 19.5  5.5 Fig. 3E, G
gal-T1-P6>A-GFP 19.6  4.0 21.1  7.7 Fig. 3F, H
fuc-T6-GFP 8.0  2.4 36.5  4.1 Fig. 5E, G
fuc-T6-D2P3>AA-GFP 11.4  3.0 9.3  2.5 Fig. 5F, H
gal-T1-E5>D-GFP 13.3  4.8 24.9  6.1 Fig. 6E, G
fuc-T6-D2>E-GFP 9.7  1.9 22.0  5.9 Fig. 6F, H
n= 4 – 6
* From Schaub et al. [4]
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D2>E-GFP exhibit a reduced redistribution to swol-
len vesicles compared with their wild-type counter-
part. This reduction indicates a requirement for
additional structural features in the respective cyto-
plasmic tails.
Discussion
Thediscovery of a traffickingmotif operating between
the GA and the TGN addresses important aspects on
the transition from the GA to the TGN. In fact,
virtually nothing is known about this step. While a
consensus on mechanisms of intra-Golgi transport
centers on the cisternal maturationmodel [24, 25], the
transition fromGolgi to TGN is still an enigma. In our
view, trans-Golgi cisternae and the TGN are, for three
main reasons, distinct, stable entities: first, brefeldinA
induces retrograde flow of Golgi membrane proteins
to the ER on one hand [26], and centers TGN
membrane proteins around the mitochondrial organ-
ization center on the other hand [27], and thus defines
a division between both organelles. Second, the TGN
may be delineated by its standard marker protein
TGN38/46 whose steady-state distribution excludes
the trans-Golgi cisterna as defined by gal-T1 local-
ization [28]. Finally, the transition of proteins from the
Figure 5. (A – D) Fluorescence of HepG2 cells stably transfected
with fuc-T6-GFP and fuc-T6-D2P3>AA-GFP (green) and immu-
nolabeled with a monoclonal antibody against gal-T1 (red). Both
mutants co-localize with endogenous gal-T1 (A and B, respective-
ly) in untreated cells. Upon treatment with 2 mM monensin for
30 min fuc-T6-GFP is redistributed to swollen vesicles where it co-
localizes togetherwith endogenous gal-T1 (C).Unlike fuc-T6-GFP,
the mutant fuc-T6-D2P3>AA-GFP is insensitive to monensin
treatment and remains associated with the GA (D). Bar 10 mm.
(E – H) OptiPrep density gradient of HepG2 cells stably trans-
fected with fuc-T6-GFP or fuc-T6-D2P3>AA-GFP. Both fuc-T6-
GFP and fuc-T6-D2P3>AA-GFP culminate in fractions 4 and 5 in
untreated cells (E andF). A clear shift towards lighter fractions can
be observed upon treatment with 2 mM monensin for 30 min for
fuc-T6-GFP (G), while themutant fuc-T6-D2P3>AA-GFP remains
concentrated in fractions 4 and 5 (H).
Figure 6. (A – D) Fluorescence of HepG2 cells stably transfected
with gal-T1-E5>D-GFP and fuc-T6-D2>E-GFP (green) and im-
munolabeled with a monoclonal antibody against giantin (red).
Both mutants co-localize with giantin (A and B, respectively) in
untreated cells. Upon treatment with 2 mM monensin for 30 min
most of gal-T1-E5>D-GFP and fuc-T6-D2>E-GFP remain asso-
ciated with the GAwhere they co-localize with giantin, and only a
small fraction separates from the GA and is found in swollen
vesicles (C and D, arrows). Bar 10 mm. (E – H) OptiPrep density
gradient of HepG2 cells stably transfected with gal-T1-E5>D-GFP
or fuc-T6-D2>E-GFP. Both gal-T1-E5>D-GFP and fuc-T6-D2>E-
GFP culminate in fractions 4 and 5 in untreated cells (E and F). A
slight shift towards lighter fractions can be observed upon treat-
ment with 2 mM monensin for 30 min (G and H), indicating a
strongly reduced monensin sensitivity of the two mutants.
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trans-Golgi cisterna to the TGN takes 4 min, as
measured by Mironov et al. [29], which is similar to
the time measured for the transition from the ER to
the cis-Golgi (also 4 min) and much slower than the
transfer through the individual Golgi cisternae
(2 min), indicating a more complex trafficking step
for the transition from trans-Golgi cisterna to TGN.
These dynamics support the assumption of a discrete
transition step from theGA to theTGN.Herewe used
monensin as a short-term read out system to further
analyze this trafficking step. How this step is mediated
is unclear at present.However, our data suggest that in
addition to the present model of cisternal maturation
and retrograde trafficking of resident proteins, further
mechanisms are required to explain the transition
from the trans-Golgi cisterna to the TGN. Both gal-
T1-E5P6>AA-GFP and fuc-T6-D2P3>AA-GFP are
retained in the trans-Golgi cisterna at steady state by
retention or recycling. The [DE]P motif would there-
fore provide additional functionality by either retain-
ing the two glycosyltransferases in the maturing
cisterna for delivery to the TGN by preventing their
recycling to earlier Golgi cisternae; or by sorting them
into transport intermediates capable of delivering
them from the trans-Golgi cisterna to the TGN.
The presence of the [DE]P motif in addition to the
retention/recycling signal would require some sort of
switch to alternate between them. The experiments
performed byHathaway et al. [30] and Reynolds et al.
[31] indicated the possibility that phosphorylation
might be involved for this step. However, we could not
find any evidence in support of the involvement of
phosphorylation for monensin sensitivity of gal-T1
[4]. Furthermore, fuc-T6 has no potential phosphor-
ylation site in its cytoplasmic tail excluding a direct
regulation of fuc-T6 by phosphorylation.
A possible reason for the presence of the signal
mediating Golgi to TGN transport may be the
facilitation of a so-called ectopic localization [32] or
displacement to a post-Golgi processing site. Both gal-
T1 and fuc-T6 are known to occur in a soluble form in
body fluids in vivo [33, 34]; the processing site and the
corresponding proteases remain to be determined. As
already pointed out by Pfeffer [35] in a recent review
and by Tu et al. [36], there seems to be no unique
mechanism governing trafficking of glycosyltransfer-
ases. This somewhat sobering conclusion is also high-
lighted by the role attributed to the conserved
oligomeric Golgi complexes (COGs) believed to
mediate retrograde transport of Golgi cisternal ele-
ments. In this context, several Golgi components were
examined for their COG dependency: here again,
someof themwere shown to depend onCOGs, termed
GEARs [37], others not. More recently, Vps74p and
TMF/ARA180 have been suggested to directly medi-
ate Golgi localization of glycosyltransferases by
interaction with their cytoplasmic domain, although
it is unclear at which stage they operate [7, 38].
However, it has been suggested that VPS74p is
involved in retrograde trafficking of glycosyltransfer-
ases [36].
A thorough bio-informatics analysis was performed
to search for membrane proteins containing the
[ED]P motif close to the cytoplasmic terminus
(Tables 2, 3 and S1). To identify proteins with trans-
membrane domains and their topology, the method
described by Kall et al. [39] was used and the
database was subsequently scanned for the motif.
The resulting proteins were sorted by membrane
topology. Of the 101 type II proteins (see Table S1),
those that were known to be localized to the ER,
nucleus, mitochondria and cytosol were excluded.
The remaining 82 proteins were further attributed to
relevant groups (Table 2). Out of the 304 type I
proteins, only 13 contained the motif at the C termi-
nus in the cytosol. The most prominent group of
proteins containing the [ED]P motif comprises the
transporters and carriers (Table S1). Since plasma
membrane localization of those proteins is tightly
regulated (reviewed in Bradbury and Bridges [40])
one could speculate that the [DE]P motif might
mediate sorting into a specialized, regulated, exo-
cytic pathway. Another prominent group are the
proteases (Table 3). Proteases are known to be
involved in regulation of transporters (reviewed in
Hughey et al. [41]), and therefore it would make
sense that the proteases are sorted into the same
pathway. In addition, one of the proteases could
potentially be responsible for the processing of gal-
T1 and/or fuc-T6 as described above. Finally, six
proteins involved in trafficking that contain the
[DE]P motif were identified (Table 3). The most
prominent of them, the SNARE GOSR2, has been
described as mediator for the trafficking from cis-/
Table 2. Membrane proteins carrying a [DE]P signal close to the
end of their cytoplasmic tail.
Protein class Number containing a
DP or EP motif
Type II Type I
Glycosyltransferases 3
Trafficking related proteins 6
Proteases 5
Carriers and transporter 27 1
Others 32 12
Total 82 13
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medial-Golgi to trans-Golgi/TGN [42] as well as ER
to cis-Golgi [43] . It would be interesting to test
whether any of these trafficking-related proteins are
required for the monensin sensitivity of gal-T1 and
fuc-T6. This could help to elucidate the mechanism
by which proteins transit from the trans-Golgi to the
TGN.
Concerning glycosyltransferases, little is known with
respect to their specific molecular determinants for
their retention or retrieval. Apart from the kin
recognition hypothesis that may explain retention
of N-acetylglucosaminyltransferase I and mannosi-
dase II in medial-Golgi cisternae [44], the length of
the transmembrane domain in the case of sia-T1 [3]
and the cytoplasmic tail of glycolipid forming glyco-
syltransferases [6, 7, 38] were shown to have an
influence for their localization. For the sorting event
between the trans-Golgi cisterna and the TGN,
individual transmembrane domains or luminal do-
mains of either gal-T1 or sia-T1 could be excluded as
sorting determinants, shown by domain shuffling
experiments [4]. Strong evidence for signal operating
in signal-mediated anterograde trafficking was pro-
vided in the work of Reynolds et al. [31]. Using a
truncated version of a-1,3-mannosyltransferase
(Mnn1p) they showed that its retention to the
trans-Golgi cisterna is mediated by its luminal
domain. Upon knockdown of the mitogen-activated
protein kinase Hog1p, this truncated mutant of
Mnn1p was secreted, suggesting that Hog1p regu-
lates either the retention or retrieval of Mnn1p.
However, in wild-type cells the truncated Mnn1p is
not secreted, indicating that retrieval is not required
for its Golgi localization. The implication of a
luminal domain as a site for a retention signal
addresses a mechanism differing from the one
described here and that might be similar to the
mechanism required for the retention of soluble
Golgi proteins [45].
In conclusion, it appears that no direct experimental
evidence is available yet concerning the mechanism
for trans-Golgi to TGN transition. Here we show that
using monensin as a read-out system to trap gal-T1
and fuc-T6 in TGN-derived swollen vesicles, Golgi to
TGN transition involves (a) a specific set of trans-
Golgi enzymes, i.e., gal-T1 and fuc-T6, and (b) that the
signal mediating this transition consists of two critical
amino acids [ED]P located in the cytoplasmic tail of
these enzymes.
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